Dr. Kolesnick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1978 - 1981
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1978
Certifications & Licensure
- FL State Medical License 2022 - Present
- NJ State Medical License 2021 - 2025
- NY State Medical License 1980 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1991
Publications & Presentations
PubMed
- 2 citationsAnti-ceramide Single-Chain Variable Fragment Mitigates Gastrointestinal-Acute Radiation Syndrome and Improves Marrow Reconstitution, Rendering Near-Normal 90-Day Autop...Prashanth K B Nagesh, Sebastien Monette, Tambudzai Shamu, Sergio Giralt, Samantha C St Jean
International Journal of Radiation Oncology, Biology, Physics. 2024-10-01 - 1 citationsAcid sphingomyelinase inhibition induces cerebral angiogenesis post-ischemia/reperfusion in an oxidative stress-dependent way and promotes endothelial survival by regu...Ayan Mohamud Yusuf, Mina Borbor, Tanja Hussner, Carolin Weghs, Britta Kaltwasser
Cell Death & Disease. 2024-09-04 - 2 citationsDiabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy.Tim F Dorweiler, Arjun Singh, Aditya Ganju, Todd A Lydic, Louis C Glazer
Cell Metabolism. 2024-07-02
Journal Articles
- Logarithmic Expansion of LGR5+ Cells in Human Colorectal CancerEfsevia Vakiani, Philip B Paty, Richard Kolesnick, Zvi Fuks, ScienceDirect
Press Mentions
- Researchers Examine Potential Immunotherapy Option for Diabetic RetinopathyJune 21st, 2024
- MSK Research Highlights, May 24, 2024May 25th, 2024
- Potential New Treatment Option for Diabetic RetinopathyJune 18th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: